♥ 24/7 Crisis Lifeline: Call or text 988 ( 988lifeline.org ) for free, confidential support.
100% Free • Pseudonymous @Handles • Zero Data Sold to Pharma

Diabetes, Blood Sugar, Thyroid & Metabolic Health — 7 Discussions & 142 Outcome Logs

Metformin IR vs. ER dinner timing, CGM dawn phenomenon, SGLT2i eGFR dips, B12/MMA lab checks, and Levothyroxine bedtime vs. morning coffee rules.

Reset
+ + Ask a Question / Log Outcome (@Handle) in Diabetes, Thyroid & A1C...
Start Post ▾
Post in Diabetes, Thyroid & A1C (Pseudonymous @Handle • Zero-PHI)
No login or email required
★ Top-Rated in Diabetes, Thyroid & A1C: Metformin ER (Glucophage XR) (4.7 / 5 • 94% Worth It) ▾
Metformin ER (Glucophage XR) 94% Worth It (4.7 / 5)

Winning Protocol: Take 500–1,000 mg Extended-Release (ER) mid-dinner (never fasting).

$5.40/mo (Cost Plus) vs. $38 retail Full Dosing & Price Guide →
Open Question @CgmTrailWalker • 60+M • Empagliflozin 10 mg • Week 14
3 Replies

Did your eGFR dip a few points in the first month after starting Jardiance (empagliflozin) or Farxiga, and how do you handle hydration?

My cardiologist added empagliflozin 10 mg to my Metformin for kidney and heart protection. At my 4-week metabolic panel, my eGFR went from 62 down to 56, which scared me at first. My doctor explained that SGLT2 inhibitors intentionally lower intraglomerular pressure inside the kidney filters—causing a small, reversible 3–6 point 'hemodynamic dip' right at the start before preserving kidney function long-term. Sure enough, by week 12 my eGFR stabilized at 60 and my urine albumin ratio improved. For anyone taking an SGLT2 inhibitor: what did your lab trend look like over the first 3–6 months, and what daily water or hygiene habits kept you side-effect free?

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

In the EMPA-KIDNEY and CREDENCE trials, an acute reversible eGFR dip of 3–5 mL/min/1.73m² during weeks 2–4 reflects reduced glomerular hyperfiltration via tubuloglomerular feedback. A drop <30% from baseline is expected and protective; patients should hold SGLT2 inhibitors during acute dehydrating illness or 3–4 days before surgery.

•
Peer Replies (3 @Handle Responses) Full Thread →
@GreatLakesKayak_MI • 60+M • Empagliflozin 10 mg • Week 40

My nephrologist warned me ahead of time so I wouldn't freak out when my patient portal pinged! Mine dipped from 54 to 49 at week 3, then sat rock-steady at 52 for the past nine months while my uACR dropped in half.

•
@SunbeltGardener_FL • 45–59F • Dapagliflozin 10 mg • Week 22

Two practical rules that helped me: (1) take it first thing in the morning with a full 16 oz glass of water so you aren't waking up twice at night to pee, and (2) rinse with water or use a bidet because you're excreting real glucose in your urine.

•
@OzarkCyclist_MO • 45–59M • Empagliflozin 10 mg • Week 18

Also remember the 'Sick Day Rule'—when I caught a stomach bug last month and couldn't keep fluids down, my endocrinologist had me pause Jardiance for 3 days until I was eating and drinking normally again to prevent euglycemic ketoacidosis.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question [What Worked For Me • Male • Age 52 • 1500mg ER + Empagliflozin 10mg]
2 Replies

[What Worked For Me • Rating: 4/5 • Duration: 24 wks • Protocol: Metformin 1500mg ER + Empagliflozin + B12 + Boswellia]

Type 2 diabetes (baseline A1C 7.6%, fasting glucose 158 mg/dL). Started metformin 1000mg ER week 1; fasting glucose plateaued at 125–135 mg/dL by week 10 despite good adherence. Added empagliflozin 10mg daily at week 8 (eGFR 68 mL/min/1.73m²). By week 12, fasting glucose 108–115 mg/dL. Escalated metformin to 1500mg ER at week 12 (split: 500mg with breakfast, 1000mg with dinner). Week 24 A1C 6.1%. Also taking B12 sublingual 1000 mcg daily (baseline 295 pg/mL), magnesium glycinate 400mg, and boswellia serrata extract 30% AKBA 500mg BID for joint inflammation (comorbid). No GI issues after week 2. Empagliflozin required baseline urine ketone check (negative).

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

Dual-agent therapy (metformin + SGLT2i) reduces A1C by 1.8–2.2% vs. monotherapy; empagliflozin is particularly effective for dawn phenomenon (PubMed 26356313). Boswellia does not interact with metformin or empagliflozin.

•
Peer Replies (2 @Handle Responses) Full Thread →
Nourhan Mansour — Literature & Label Auditor

Excellent dual-agent response. Metformin 1500mg ER + empagliflozin 10mg is a guideline-concordant step-2 regimen. Boswellia 30% AKBA is well-tolerated; no pharmacokinetic interactions. Recommend annual eGFR + urine albumin-to-creatinine ratio monitoring (empagliflozin requires eGFR ≥20).

•
Male • Age 55-69 • 1500mg ER + Empagliflozin 10mg • Week 32

Similar trajectory here. Metformin alone plateaued; empagliflozin addition was game-changing. Fasting glucose now consistently 105–112 mg/dL. A1C 5.9% at week 32. Added alpha-lipoic acid 300mg BID at week 16 for additional insulin sensitivity boost. Boswellia helps with knee pain from weight loss exercise.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question @MidwestCardioDad • 45-59F • 10mg empagliflozin + 500mg m • Week 12
2 Replies

Empagliflozin 10mg AM + 10-min post-dinner walk + ALA 600mg (12 wks update): Protocol summary from a 52-year-old with type 2 diabetes, early neuropathy, and eGFR 71 — what worked for others here?

Protocol summary from a 52-year-old with type 2 diabetes, early neuropathy, and eGFR 71. Medications: empagliflozin 10 mg at 7 a.m., metformin ER 500 mg with dinner (stepped up from IR to reduce stomach upset), and a 10-minute walk starting about 10 minutes after dinner. I also added alpha-lipoic acid 600 mg once daily on an empty stomach, after discussing it with my clinician. Results: fasting glucose fell from 148 to 121 mg/dL, A1c from 7.8% to 7.0%, and the tingling in my feet eased slightly. Changes that helped: moving empagliflozin to the morning fixed night-time urination, and I drink water steadily through the day. I check ferritin and B12 yearly because long-term metformin can lower B12 (mine was 410 pg/mL). Downside: one mild yeast infection at week 5, which cleared with treatment.

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

In the SYDNEY 2 trial, oral alpha-lipoic acid 600 mg daily for 5 weeks improved neuropathic symptom scores in type 2 diabetes. The metformin label advises monitoring B12 periodically, since low B12 can occur in some patients on long-term therapy and can mimic neuropathy.

•
Peer Replies (2 @Handle Responses) Full Thread →
@RedRockClimber_NV • Verified Cohort Member • Week 14

Good to see a B12 check, since low B12 can mimic or worsen neuropathy symptoms. A common threshold is that a level under about 200 pg/mL is deficient, and 200-300 pg/mL is borderline, where methylmalonic acid can help. Alpha-lipoic acid can lower glucose, so it's worth tracking fasting readings after adding it.

•
@FingerLakesHiker_NY • Age 45-59 • Week 16

I made a similar switch from metformin IR to ER with dinner and my stomach issues dropped a lot. I also separated my calcium and iron supplements from other pills by 2 hours. Fasting glucose is down about 20 mg/dL on empagliflozin 10 mg.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question @BayAreaBioTracker • 60+M • 10mg empagliflozin • Week 2
2 Replies

My eGFR dropped from 58 to 53 after starting empagliflozin 10 mg. Is my kidney damaged and should I stop?

Public question: "Two weeks after starting empagliflozin 10 mg for type 2 diabetes with CKD stage 3a, my eGFR fell from 58 to 53 mL/min/1.73m². Should I stop?" Evidence Desk answer: A small early dip is expected. SGLT2 inhibitors lower pressure inside the kidney's filters (afferent vasoconstriction), and trial data show an initial average fall of about 3-5 mL/min/1.73m² that then levels off. Over the long term, the drug slows eGFR decline. A drop of 30% or more from baseline, or symptoms of dehydration like dizziness and very low urine output, should prompt a call to your prescriber. Typical practice is to recheck creatinine/eGFR 2-4 weeks after starting, then every 3-6 months, and to check urine albumin-to-creatinine ratio (UACR) at least yearly. Do not stop on your own for a 5-point dip.

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

The EMPA-KIDNEY trial studied empagliflozin 10 mg daily in adults with eGFR 20-<45, or eGFR 45-<90 with UACR ≥200 mg/g, and showed a lower risk of CKD progression or cardiovascular death. The Jardiance label describes an expected early eGFR dip that is usually reversible, and advises assessing volume status and renal function before starting.

•
Peer Replies (2 @Handle Responses) Full Thread →
@SaltMarshBirder_SC • Verified Cohort Member • Week 14

One practical point from the label: check volume status before starting, especially if you also take a loop diuretic or an ACE inhibitor/ARB. Repeat the panel under similar conditions, meaning the same hydration level and not right after a hard workout, so the comparison is fair. If eGFR keeps falling at the 4-8 week recheck, that is the time to raise it with your clinician.

•
@CanyonCyclist_UT • Age 60+ • Week 8

Mine went from 49 to 44 at week 3, then held at 45-46 at weeks 8 and 16. My nephrologist told me to drink steadily through the day and skip ibuprofen. UACR improved from 410 to 280 mg/g by month 6.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question Evidence Desk Prompt • Timing & Lab Check
2 Replies

Dawn Phenomenon + Metformin: Fasting glucose still 130–145 mg/dL at week 10—protocol adjustment?

Evidence Desk Prompt • Timing & Lab Check: I'm on metformin 1000mg ER (taken with dinner) for type 2 diabetes. Fasting glucose remains 130–145 mg/dL despite 10 weeks of adherence; postprandial readings are 160–180 mg/dL. A1C baseline was 7.4%. No GI side effects. I also take atorvastatin 40mg and magnesium glycinate 400mg (separated by 2 hours). Should I request dose escalation to 1500mg ER, add a second agent (SGLT2i like empagliflozin?), or adjust timing? What labs should I request?

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

Metformin monotherapy achieves A1C reduction of 1.5–2% on average; dawn phenomenon (hepatic glucose output) often requires dual therapy. Empagliflozin 10mg daily reduces fasting glucose by 15–25 mg/dL and is synergistic with metformin (PubMed 26356313).

•
Peer Replies (2 @Handle Responses) Full Thread →
Nourhan Mansour — Literature & Label Auditor

Request fasting labs: glucose, insulin, C-peptide, lipid panel, eGFR, urine albumin-to-creatinine ratio. If eGFR >45 mL/min/1.73m², escalate metformin to 1500mg ER or add empagliflozin 10mg. Dawn phenomenon typically requires dual-agent therapy; metformin alone rarely suppresses hepatic glucose output sufficiently.

•
Male • Age 50-64 • 1000mg ER + Empagliflozin 10mg • Week 16

Added empagliflozin at week 8. Fasting glucose dropped to 108–115 mg/dL by week 16. A1C fell to 6.1%. No additional side effects. Took 6 weeks to see full benefit. Recommend requesting eGFR first—empagliflozin requires eGFR ≥20.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question @FingerLakesHiker_NY • 45-59M • 10mg SGLT2 inhibitor AM • Week 6
2 Replies

Post-dinner walk: 10 vs 15 minutes, and when to take an SGLT2 inhibitor to avoid night-time bathroom trips?

Evidence Desk Prompt • Timing & Sleep Check. Small studies in type 2 diabetes suggest that short walks of about 10-15 minutes starting within 30 minutes of a meal blunt the post-meal glucose rise more than one long walk at another time of day. One crossover trial found a 12% improvement in 3-hour post-meal glucose with three 10-minute post-meal walks, compared with one 30-minute walk. SGLT2 inhibitors are usually taken in the morning, partly because the extra urine glucose loss (roughly 60-80 g/day) can increase urination. For this thread, share the following: 1) Your walking length and how soon after dinner you start. 2) The time you take empagliflozin or dapagliflozin. 3) Whether night-time urination or poor sleep changed after you shifted timing. 4) Any 2-hour post-dinner glucose readings, if you track them. Please do not change medicines without your prescriber.

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

Reynolds et al. (Diabetologia, 2016) found that 10-minute walks after each meal lowered 3-hour post-meal glucose by about 12% versus a single 30-minute walk in adults with type 2 diabetes. Empagliflozin and dapagliflozin labels advise once-daily morning dosing and note increased urination as a common effect.

•
Peer Replies (2 @Handle Responses) Full Thread →
@SonoranSunrise_AZ • Age 45-59 • Week 12

I walk 12 minutes starting about 10 minutes after dinner, and I take empagliflozin at 7 a.m. My 2-hour post-dinner reading dropped from about 190 to about 155 mg/dL. Night-time urination went from twice to once after I stopped drinking big glasses of water after 8 p.m.

•
@MidwestCardioDad • Age 60+ • Week 9

My knees limit me, so I do 3 laps around the kitchen and den for 10 minutes after dinner. It helped my glucose a little. Taking dapagliflozin before 9 a.m. stopped my sleep interruptions. I also use a night light for safer bathroom trips.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected
Open Question @DesertRunner_AZ • 30-44F • 10mg dapagliflozin or empagl • Week 12
2 Replies

Generic SGLT2 cash prices and lab schedule: what do you pay and how often is eGFR checked?

Evidence Desk Prompt • Cash Price & Lab Cadence. Cost is a common reason people skip SGLT2 inhibitors. Prices differ widely by pharmacy, by coupon program, and by whether a generic is available for your strength, so please share a range instead of a single number. Useful details: 1) Drug and strength (for example dapagliflozin 10 mg, 30 tablets). 2) Pharmacy type and whether you used a discount card, manufacturer savings program, or mail order. 3) Your cash price and, if applicable, 90-day price. 4) How often your clinician checks creatinine/eGFR, UACR, and A1c. Reference points: many guidelines suggest eGFR and UACR at least once a year in diabetes, and more often (every 3-6 months) if eGFR is under 60. Prices change often, so include the month you filled.

⚙ Pinned AI Clinical & Label Audit: dotMD-StoichBot (NIH DSLD v9 & PubMed PK Agent)

KDIGO and ADA Standards of Care recommend annual eGFR and urine albumin-to-creatinine ratio testing in people with type 2 diabetes, and more frequent monitoring when eGFR is below 60 mL/min/1.73m². Labels for empagliflozin and dapagliflozin advise assessing renal function before starting and periodically afterward.

•
Peer Replies (2 @Handle Responses) Full Thread →
@MaintenanceMode_WA • Age 30-44 • Week 14

I compared three pharmacies and a mail-order service for 90 tablets. The price gap between the highest and lowest was well over double. Calling ahead and asking for the cash price with and without a coupon saved me real money. My labs are every 3 months.

•
@SpineRecovery_PA • Verified Cohort Member • Week 29

Tip: ask the pharmacist whether the product is a true generic or a brand-name authorized product, since pricing differs. Also confirm the tablet strength matches your prescription. Insurance can sometimes be cheaper than coupons, but coupon use may not count toward a deductible, so compare both.

•
Add your reply or share what worked for you (no login required)... Reply
Pseudonymous @Handle • Zero-PHI Protected